A one-time cell therapy from Kyverna Therapeutics for stiff person syndrome, a rare disease, improved mobility and reduced ...

At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, and Anthony Letai declared ...

Lawmakers seem poised to reject cuts to biomedical research and public health spending for a second straight year.

WASHINGTON — The Trump administration’s plan for providing cheap weight-loss drugs to seniors in Medicare might be falling ...

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, ...

The Senate GOP doctors who will question RFK Jr. There are four Republican doctors on two of the Senate committees at which ...

Tortugas Neuroscience launched Tuesday with plans to develop drugs licensed from Chinese drugmaker Jiangsu Hansoh and ...

Defense Secretary Pete Hegseth announced Tuesday that the U.S. military will no longer require all American troops to get the ...

The Trump administration has been heavily focused on combating purported fraud in federal health care programs.

BioAge Labs said its investigational pill for cardiovascular risk prevention significantly reduced inflammation in an early ...

A U.S. judge is expected to direct Purdue Pharma to forfeit $225 million to the Justice Department, clearing the way for a ...

BioAge is making its way into the race among drug companies to target inflammation as a way to treat chronic conditions.